Two FDA Approvals on Same Day Renew Hope for Pulmonary

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community

CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for Idiopathic Pulmonary Fibrosis (IPF). Expected to come separately by the end of November, the surprise FDA decisions on both drugs came on Wednesday.

The FDA approved InterMune's Esbrriet (pirfenidone) and Boehringer Ingelheim's Ofev (nintedanib) for IPF.

TV, Film and Broadway actress Barbara Barrie, who disclosed recently she has been diagnosed with IPF, is working with non-profit foundation, the Coalition for Pulmonary Fibrosis (CPF), to raise awareness of the little known disease.  Barrie's diagnosis three years ago has not slowed the actress down.  Like some IPF patients, she is able to carry on a busy, active life without supplemental oxygen or limitation.

"As a patient who has been dealing with this disease," said Barrie, "this news is a huge gift to me and to anyone else fighting Pulmonary Fibrosis."

Sports radio host George Lapides has spoken publicly on his Memphis-based radio show about his diagnosis with IPF and also appeared in a documentary on the disease that aired recently on the Discovery Channel (visit www.everybreathcountsfilm.com to view).  "For those of us with IPF, this is fantastic.  We have been hoping this would happen for a long time and now that it has, it gives hope to so many of us."

The drugs are the first FDA approved therapies for the disease that affects 200,000 Americans and claims as many lives each year as breast cancer.  IPF is a lethal lung disease characterized by scarring that is irreversible, progressive and deadly in an average of three years

On September 26th, the FDA held the first IPF Workshop to hear directly from patients, families and caregivers about their experiences with the disease.  Patients and family members of deceased IPF patients spoke about the hardships of IPF, a disease that debilitates patients early in its course and produces a steady decline in quality of life and gradual worsening of symptoms such as shortness of breath, cough and fatigue as well as issues with anxiety and depression.

IPF survivor, Heather Snyder, who received a lung transplant a few years ago, was one of the eight FDA panelists at the IPF Workshop.  Snyder lost her father to the disease when she was a child in the 1980s.  "I never thought I'd see this day," she said.  "It is historic and hopeful yet frustrating and sad at the same time that it has taken so long."

The research community seems equally hopeful with the news of approvals.  "The Food and Drug Administration approval of nintedanib and pirfenidone in the treatment of idiopathic pulmonary fibrosis (IPF) comes as welcome news, certainly for the brave patients who struggle with this deadly respiratory disease every day," said Thomas Ferkol, MD, president of the American Thoracic Society (ATS).  "These approvals were the result of continued investments in IPF research, clinical care and increasing awareness among the public.  It is truly gratifying news for the respiratory community."  

The ATS and CPF have partnered on over a million dollars in research in the last decade in IPF.  

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring – known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 200,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis.  Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501C(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 28,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=28404
 

For actress Barbara Barrie, patients: Teresa Barnes Coalition for Pulmonary Fibrosis 303-521-4080 For Dr. Tom Ferkol and respiratory experts: Rory Williams American Thoracic Society 415-235-5976 mobile 212-315-8631 office

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midea's Cooling Systems Take Center Stage at DCW ME

Updated Category News Views 64

AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 141

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 23

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
Teen Adoption Campaign Makes Room for Mutual Growth

Updated Category News Views 8

A bicycle wobble and a ballet count carry more weight than they first appear to. The new Adoption from Foster Care public service ads put teens in the instructor's spot: a son helps his mother learn to ride a bike in Two Wheeler, while a daughter walks her father through ballet in Routine. It is a small creative reversal, but a smart one. Teen adoption is too often framed...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 149

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 80

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading

Top 5 Most Recently Viewed Articles

Embassy Bancorp, Inc. Reports Strong Financial Growth for Q2

Updated Category News Views 197

Embassy Bancorp, Inc. Financial Results Overview Embassy Bancorp, Inc. (OTCQX: EMYB) has recently released a comprehensive report highlighting its operations and financial achievements for the quarter ended June 30, 2025. The report outlines the ongoing stability and growth of the company, reinforcing its position in the competitive banking landscape. Key Financial...

Continue Reading
Unlocking New Features: Wijmo 2025 v2 by MESCIUS USA, Inc.

Updated Category News Views 200

Wijmo 2025 v2: A Leap Forward in Enterprise Software MESCIUS USA Inc. has officially launched Wijmo 2025 v2, marking the last major release for the year. This version not only promises cutting-edge features but also showcases their commitment to enhancing developer experiences across frameworks. Included in this release is robust support for Angular 20 and Nuxt.js 4,...

Continue Reading
Titan Investors Teams with Corridor for Global Expansion

Updated Category News Views 42

Titan Investors Takes a Bold Leap Forward Alright folks, here's a change in the wind that's got my attention. Titan Investors, a heavyweight in the investment event business, has just locked arms with Corridor Capital. Yeah, we're talking about a private equity firm with a knack for boosting the game of middle-market business services across North America. If you're...

Continue Reading
Examining the Implications of a 'Shadow' Fed Chair Role

Updated Category News Views 166

The Emerging Concept of a ‘Shadow’ Fed Chair There has been growing tension surrounding Chairman Powell, particularly with rising frustration from Donald Trump. Reports indicate that Trump may expedite his decision on Powell's successor, creating anticipation for a so-called 'shadow Fed Chair' who would shape economic opinions until Powell's term concludes in 2026....

Continue Reading
U.S. Postal Service Reports Growth and Financial Improvements

Updated Category News Views 294

U.S. Postal Service Financial Results Overview The U.S. Postal Service has recently shared its financial outcomes for the first quarter of fiscal year 2025, revealing impressive growth metrics that mark a significant turnaround from previous years. Controllable income has doubled to $968 million, a substantial increase from $472 million during the same period last year,...

Continue Reading